Two center evaluation of the safety and efficacy of topical nasal rEV131 [recombinant EV 131] versus rEV131 vehicle (placebo) in the prevention of the signs and symptoms of allergic rhinitis induced by nasal allergen challenge,

Trial Profile

Two center evaluation of the safety and efficacy of topical nasal rEV131 [recombinant EV 131] versus rEV131 vehicle (placebo) in the prevention of the signs and symptoms of allergic rhinitis induced by nasal allergen challenge,

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 16 Jan 2017

At a glance

  • Drugs EV 131 (Primary)
  • Indications Allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Evolutec
  • Most Recent Events

    • 22 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top